Consumer Cause, Inc. v. Johnson & Johnson

34 Cal. Rptr. 3d 258, 132 Cal. App. 4th 1175, 2005 Daily Journal DAR 11635, 2005 Cal. Daily Op. Serv. 8572, 2005 Cal. App. LEXIS 1495
CourtCalifornia Court of Appeal
DecidedSeptember 22, 2005
DocketB176381
StatusPublished
Cited by19 cases

This text of 34 Cal. Rptr. 3d 258 (Consumer Cause, Inc. v. Johnson & Johnson) is published on Counsel Stack Legal Research, covering California Court of Appeal primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Consumer Cause, Inc. v. Johnson & Johnson, 34 Cal. Rptr. 3d 258, 132 Cal. App. 4th 1175, 2005 Daily Journal DAR 11635, 2005 Cal. Daily Op. Serv. 8572, 2005 Cal. App. LEXIS 1495 (Cal. Ct. App. 2005).

Opinion

Opinion

ARMSTRONG, J.

This is a Proposition 65 (Health & Saf. Code, § 25249.5 et seq.) 1 case brought by a private organization called Consumer Cause, Inc., against a number of manufacturers of stainless steel surgical stents and similar implantable surgical devices. 2 The complaints alleged that the devices were composed of nickel and nickel compounds, chemicals known to the state to cause cancer, and that the manufacturers had failed to warn consumers of the exposures, thus violating section 25249.6, which provides that “[n]o person in the course of doing business shall knowingly and intentionally expose any individual to a chemical known to the state to cause cancer . . . without first giving clear and reasonable warning . . . .” The case was resolved with a consent judgment which was approved by the trial court (§ 25249.7, subd. (f)(4)) and which included an award of $58,000 in attorney fees to Consumer Cause.

*1179 The appeal was filed by the Attorney General, who objected to the settlement below. 3 (§ 25249.7, subd. (f)(5).) He argues, inter alia, that the warnings specified in the consent judgment do not satisfy the statute, and that although the consent judgment purports to apply to a long list of implantable surgical devices, plaintiff had no authority to settle claims as to many of those devices because they were not included in the preliminary notices. (§ 25249.7, subd. (d)(1).) We saw a more fundamental problem, that of justiciability, and asked the parties to brief that issue.

Both defendants and the Attorney General responded, arguing, inter alia, that the trial judge had discretion to enter the judgment. We have concluded that this case does not, and has not for some time, presented a justiciable controversy, and should have been dismissed. Although the case was apparently filed in the good faith belief that defendants were in violation of the statute, by the time the trial court entered the consent judgment, plaintiff no longer held that belief. In its motion seeking court approval of the settlement, plaintiff wrote that no civil penalty was warranted “because the Parties have determined that the Covered Products currently and previously distributed in California have not violated Proposition 65 and that all Covered Products fall within the ‘no significant risk level’ provided under Proposition 65.” 4

Defendants took the same position. During the proceedings concerning the approval of the consent judgment, they filed an expert declaration to the effect that “the specific products at issue in this action posed a no significant risk level of exposure and, as currently marketed, did not require a warning under Proposition 65.”

The substance of the consent judgment is in accord. It does not mandate a warning for any product now manufactured by any of the defendants. Instead, it specifies the warnings to be given if any of the defendants—or, under the opt-in procedures of the judgment, any other manufacturer of similar devices—ever in the future manufactures a device which requires a warning. It is, in plaintiff’s words, meant to “act prophylactically to avert future violations and to mandate warnings where required by Proposition 65.”

*1180 We do not see that either Proposition 65 or the rules pertaining to justiciability allow such purely prospective and speculative litigation. Further, in our view, there is nothing to be gained by such litigation. Proposition 65 itself “mandates warnings,” and “averts violations” by making exposure without a warning unlawful and subject to penalties.

Given the lack of justiciable controversy, the consent judgment must be vacated. Further, given plaintiff’s concession that the complaint has no merit, the complaint must be dismissed.

Background 5

Under Proposition 65, any person who “violates or threatens to violate” section 25249.6 may be enjoined, and “any person who has violated” that statute is liable for civil penalties. (§ 25249.7, subds. (a), (b).) A private person may bring an enforcement action “in the public interest” if a 60-day notice is given to the alleged violator and to the Attorney General and local prosecutor and if neither the Attorney General or the local prosecutor is diligently prosecuting an action against the violation. (§ 25249.7, subds. (d)(1), (2).)

Consumer Cause filed such an action. It alleged that defendants manufactured, distributed, and sold surgical implants composed of nickel and nickel compounds, chemicals known to the State of California to cause cancer, that when the devices were implanted they would leach chemicals into the body (or, in some of the complaints, that they would expose vital organs to the chemicals), and that defendants had failed to give warnings to the persons into whose bodies the devices were implanted, thus violating section 25249.6. The complaints did not allege that defendants threatened to violate the statute.

The complaints against Johnson & Johnson, Ethicon, and Cordis list only one product each, “stainless steel sutures,” or “stainless steel coronary stents.” The complaint against Sofamor Danek Group, Inc., Medtronic, Inc., and Sofamor Danek Manufacturing lists nine, all with general descriptions such as “surgically implantable metallic rods,” or “surgically implantable metallic hooks,” while the complaint against Howmedica, Howmedica Osteonics Corporation and Stryker Corporation lists 79 products, ranging from the general (“surgically implantable metallic screws”) to the specific (“Omego Plus Compression Hip Screw System,” or “Leibinger King Combo”).

*1181 In addition to the section 25249.6 cause of action described ante, the complaints brought causes of action under Business and Professions Code section 17200, alleging that defendants violated that statute through an unlawful action, the violation of section 25249.6.

Plaintiff sought injunctive relief, civil penalties, and, under the Business and Professions Code section 17200 cause of action, disgorgement and restitution. (The consent judgment does not include any of those remedies.)

The cases were filed in February 2000. In November of that year, the trial court issued a case management order identifying issues of law and fact. The fact questions included: “Do the medical devices contain nickel? . . . What is the lifetime exposure to nickel, if any, from implanted medical devices? . . . What is the appropriate no significant risk level for exposure assessment to nickel released from implanted medical devices, if any? ... Is the level of nickel released into the body, if any, above the ‘no significant risk level’ of exposure necessitating a Proposition 65 warning?”

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Consumer Advocacy Group, Inc. v. Walmart, Inc.
California Court of Appeal, 2025
Equinix LLC v. County of Los Angeles
California Court of Appeal, 2024
Stewart v. Superior Court CA2/1
California Court of Appeal, 2022
Marriage of Tearse CA1/4
California Court of Appeal, 2021
Villanueva v. Becerra CA5
California Court of Appeal, 2021
Cleveland Nat'l Forest Found. v. San Diego Ass'n of Governments
225 Cal. Rptr. 3d 591 (California Court of Appeals, 5th District, 2017)
Association of Irritated Residents v. Department of Conservation
11 Cal. App. 5th 1202 (California Court of Appeal, 2017)
Cuenca v. Cohen
8 Cal. App. 5th 200 (California Court of Appeal, 2017)
Harrell v. Hanson CA3
California Court of Appeal, 2016
DeSilva Gates Construction, LP v. Department of Transportation
242 Cal. App. 4th 1409 (California Court of Appeal, 2015)
Rea v. Blue Shield of California
226 Cal. App. 4th 1209 (California Court of Appeal, 2014)
Wilson & Wilson v. City Council
191 Cal. App. 4th 1559 (California Court of Appeal, 2011)
Ebensteiner Co., Inc. v. Chadmar Group
49 Cal. Rptr. 3d 825 (California Court of Appeal, 2006)
Ebensteiner Co. v. Chadmar Group
143 Cal. App. 4th 1174 (California Court of Appeal, 2006)
Consumer Advocacy Group, Inc. v. Kintetsu Enterprises of America
45 Cal. Rptr. 3d 647 (California Court of Appeal, 2006)
Consumer Defense Group v. Rental Housing Industry Members
40 Cal. Rptr. 3d 832 (California Court of Appeal, 2006)

Cite This Page — Counsel Stack

Bluebook (online)
34 Cal. Rptr. 3d 258, 132 Cal. App. 4th 1175, 2005 Daily Journal DAR 11635, 2005 Cal. Daily Op. Serv. 8572, 2005 Cal. App. LEXIS 1495, Counsel Stack Legal Research, https://law.counselstack.com/opinion/consumer-cause-inc-v-johnson-johnson-calctapp-2005.